BRYCE JAMES: Open Payments
NPI 1386201440 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 88 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $300 · 2025 $1,600
Food & beverage: $1,600
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 36 | $633 |
| ViiV Healthcare Company | 35 | $618 |
| Merck Sharp & Dohme LLC | 6 | $130 |
| EMD Serono, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| Lilly USA, LLC | 2 | $37 |
| Verity Pharmaceuticals Inc. | 1 | $25 |
| Antares Pharma, Inc. | 1 | $18 |
| Napo Pharmaceuticals Inc | 1 | $15 |
Products named: CABENUVA, DOVATO, APRETUDE, PIFELTRO, MAVYRET, Wegovy, Biktarvy, Tlando.
Industry payments across AZ — which companies pay providers there.
